Advocacy Spotlight

Today’s Promise, Tomorrow’s Progress

LUNGevity funds innovative research that helps people live better and longer with lung cancer

Text Size

Lung cancer is the leading cause of cancer death in the United States today, claiming approximately 160,000 lives each year. That is more than breast, colon, and prostate cancers combined.  In the last several years, however, increased treatment options and advancement in early detection give the lung cancer community reason to hope.

The LUNGevity Foundation, the nation’s leading lung cancer nonprofit, increasingly funds the most promising investigators and studies in the field.  Funded projects focus on early detection and innovative treatments – from immunology, which can harness the strength of a person’s immune system to fight disease, to personalized treatments, which address specific genetic alterations.

The lung cancer studies and research projects in development today mean an increase in options for survivors tomorrow, as well as significant improvements in quality of life.  LUNGevity funds research that improves mortality rates and allows survivors to live better with the disease.

In addition to supporting critical research, LUNGevity has built a strong, supportive lung cancer community that continues to grow and thrive, in part due to more than 80 awareness building and fundraising events across the country each year.  LUNGevity’s online community is the largest online lung cancer support network, providing its members educational information about the disease, updates on treatments and clinical trials, and a platform for survivors and their family members to connect with others sharing similar experiences.

Andrea Ferris, president and chairman of LUNGevity, became involved in lung cancer research after losing her mother to the disease in 2008.  She was inspired to make a difference for others who were battling lung cancer, and through LUNGevity has been able to spearhead initiatives that provide critical support for the lung cancer community, raise awareness of the disease, and fund life-changing research. “I am lucky to have already witnessed results of the progress we are making in the fight against lung cancer,” she says.  “We still have a long road ahead, but there is no shortage of extraordinary people – researchers, advocates, and survivors – working with us to create a world where no one dies of lung cancer.”

For more information about LUNGevity, visit